Taro Announces Joining of CEO

05-Sep-2017 - USA

Taro Pharmaceutical Industries Ltd. announced that Mr. Uday Baldota has joined the Company as its Chief Executive Officer (“CEO”) effective August 28, 2017. Since December 2016, Mr. Baldota has served as a member of Taro’s Board of Directors (“Taro Board”).

Mr. Baldota replaces Mr. Abhay Gandhi, who served in the role of Interim Chief Executive Officer since January 1, 2017. Mr. Gandhi will continue in his role as Vice Chairman of the Taro Board and as the CEO of the Sun Pharma North America operations.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances